Skip to content

US Physical Therapy USPH Income Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$795.49M+1.9%$780.99M+2.9%$758.71M+4.0%$729.61M+4.3%$699.46M+4.2%
$151.38M+1.1%$149.69M+5.4%$142.09M+5.8%$134.35M+6.1%$126.59M+2.1%
19%-0.1pp19.2%+0.4pp18.7%+0.3pp18.4%+0.3pp18.1%-0.4pp
$71.29M+2.9%$69.26M+3.8%$66.71M+4.8%$63.68M+5.3%$60.45M+3.7%
$644.11M+2.0%$631.3M+2.4%$616.62M+3.6%$595.27M+3.9%$572.87M+4.6%
$79.52M-8.3%$86.68M-3.2%$89.56M+16.2%$77.08M+13.8%$67.71M+7.5%
10%-1.1pp11.1%-0.7pp11.8%+1.2pp10.6%+0.9pp9.7%+0.3pp
-$8.47M+4.5%-$8.86M-5.7%-$8.38M-30.2%-$6.44M-30.7%-$4.93M-76.9%
13,390,400,000%-676,500,000%14,066,900,000%+1,760,400,000%12,306,500,000%+1,053,900,000%11,252,600,000%+785,800,000%10,466,800,000%+257,200,000%
$18.36M-7.3%$19.81M-0.2%$19.85M+15.6%$17.18M+12.1%$15.33M+4.9%
$34.72M-12.3%$39.58M-11.4%$44.67M+17.1%$38.16M+14.7%$33.28M+5.9%
4.4%-0.7pp5.1%-0.8pp5.9%+0.7pp5.2%+0.5pp4.8%+0.1pp
$2.38+3.9%$2.29+5.0%$2.18+18.5%
$102.04M-6.4%$109.07M-3.5%$113M+14.1%$99.07M+12.4%$88.16M+7.9%
12.8%-1.1pp14%-0.9pp14.9%+1.3pp13.6%+1.0pp12.6%+0.4pp
$79.52M-8.3%$86.68M-3.2%$89.56M+16.2%$77.08M+13.8%$67.71M+7.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is US Physical Therapy's revenue?
US Physical Therapy (USPH) generated $795.5M in revenue over the trailing twelve months, up 13.7% year over year.
Is US Physical Therapy profitable?
US Physical Therapy reported $34.7M in net income over the trailing twelve months, a 4.4% net margin.
What are US Physical Therapy's profit margins?
Gross margin is 19.0% and operating margin is 10.0%, with a 4.4% net margin.
What is US Physical Therapy's earnings per share?
US Physical Therapy's diluted EPS over the trailing twelve months is $1.74.
Where does US Physical Therapy's income statement data come from?
Every line is extracted from US Physical Therapy's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.